EUVIMEDEUVIMED entdecken
Crossref

poxtA amplification and mutations in 23S rRNA confer enhanced linezolid resistance in Enterococcus faecalis

Xinxin Shan, Chenglong Li, Likuan Zhang, Chenhui Zou, Runhao Yu, Stefan Schwarz iD, Yanhong Shang, Dexi Li, Andrea Brenciani iD, Xiang-Dang Du iD

Journal of Antimicrobial Chemotherapy · 02.12.2024 · 79 (12) · 3199-3203

DOI: 10.1093/jac/dkae342 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 27.09.2024. Verfasst von Xinxin Shan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Animal-Derived Food Safety Innovation Team, College of Animal Science and Technology, Anhui Agricultural University, Hefei 230036, China. Hauptthemen laut MEDLINE: Linezolid, RNA, Ribosomal, 23S, Enterococcus faecalis, Drug Resistance, Bacterial. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Outstanding Foreign Scientist Studio in Henan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This study aimed to explore the evolutionary patterns and resistance mechanisms of an Enterococcus faecalis strain harbouring poxtA under linezolid exposure.

Methods

A poxtA-carrying E. faecalis electrotransformant DJH702 with a linezolid minimum inhibitory concentration of 4 mg/L was exposed to increasing concentrations of linezolid (8–64 mg/L). The derived strains growing at 8, 16, 32 and 64 mg/L, designed DJH702_8, DJH702_16, DJH702_32 and DJH702_64, were obtained. The amplification and overexpression of poxtA were measured using sequencing and RT–PCR, the fitness cost by competition assays and the stability of the repeat units by serial passage.

Results

In all derived strains, high-level linezolid resistance develops through poxtA amplification. The relative copy numbers and transcription levels of poxtA were significantly increased. However, in the presence of higher linezolid concentrations, DJH702_32 and DJH702_64 showed reduced poxtA copy numbers and transcription levels compared with DJH702_8 and DJH702_16, but additional mutations in the 23S rRNA (G2505A). IS1216E-mediated formation of translocatable units with subsequent tandem amplification of these translocatable units supported the gain of poxtA segments. However, these amplicons were not stable and were lost frequently in the absence of a linezolid selection pressure. The amplification of the poxtA region did not result in a fitness cost, but mutations in 23S rRNA did. Conclusions poxtA-carrying E. faecalis electrotransformants used two distinct mechanisms to resist linezolid selection pressure: at lower concentrations, strains prioritized increasing poxtA expression levels, while at higher concentrations, a combination of increased poxtA expression and mutations in 23S rRNA was observed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LinezolidRNA, Ribosomal, 23SEnterococcus faecalisDrug Resistance, BacterialAnti-Bacterial AgentsMicrobial Sensitivity TestsMutationSequence Analysis, DNAHumansBacterial Proteins

Substanzen

LinezolidRNA, Ribosomal, 23SAnti-Bacterial AgentsBacterial Proteins

Autor:innen und Institutionen

  • Animal-Derived Food Safety Innovation Team, College of Animal Science and Technology, Anhui Agricultural University, Hefei 230036, China.
  • College of Veterinary Medicine, Henan Agricultural University, Zhengzhou 450046, China.
  • Institute of Microbiology and Epizootics, Centre for Infection Medicine, Department of Veterinary Medicine, Freie Universität Berlin, Berlin, Germany.
  • Veterinary Centre of Resistance Research (TZR), Freie Universität Berlin, Berlin, Germany.
  • Unit of Microbiology, Department of Biomedical Sciences and Public Health, Polytechnic University of Marche Medical School, Ancona, Italy.

ORCID-Profile: Stefan Schwarz, Andrea Brenciani, Xiang-Dang Du

Förderung

  • National Natural Science Foundation of China
  • Outstanding Foreign Scientist Studio in Henan Province

Zitieren

APA

Shan, X., Li, C., Zhang, L., Zou, C., Yu, R., Schwarz, S., Shang, Y., Li, D., Brenciani, A., & Du, X. D. (2024). poxtA amplification and mutations in 23S rRNA confer enhanced linezolid resistance in Enterococcus faecalis. Journal of Antimicrobial Chemotherapy, 79(12), 3199-3203. https://doi.org/10.1093/jac/dkae342

Vancouver

Shan X, Li C, Zhang L, Zou C, Yu R, Schwarz S, et al. poxtA amplification and mutations in 23S rRNA confer enhanced linezolid resistance in Enterococcus faecalis. Journal of Antimicrobial Chemotherapy. 2024;79(12):3199-3203. doi:10.1093/jac/dkae342

BibTeX
@article{Shan2024,
  author = {Shan, Xinxin and Li, Chenglong and Zhang, Likuan and Zou, Chenhui and Yu, Runhao and Schwarz, Stefan and Shang, Yanhong and Li, Dexi and Brenciani, Andrea and Du, Xiang-Dang},
  title = {poxtA amplification and mutations in 23S rRNA confer enhanced linezolid resistance in Enterococcus faecalis},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2024},
  volume = {79},
  number = {12},
  pages = {3199--3203},
  doi = {10.1093/jac/dkae342}
}
Kostenlos starten →